1h Free Analyst Time
The carrier screening market is forecasted to grow by USD 3.89 billion during 2024-2029, accelerating at a CAGR of 22.5% during the forecast period. The report on the carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic diseases and disorders, increasing prevalence of fetal chromosomal abnormalities, and rising consciousness among masses regarding benefits of early detection and diagnosis of diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The carrier screening market is segmented as below:
By Type
- Expanded
- Targeted disease
By Technology
- DNA sequencing
- Polymerase chain reaction (PCR)
- Microarrays
- Others
By Test
- Molecular screening tests
- Biochemical screening tests
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the carrier screening market covers the following areas:
- Carrier Screening Market sizing
- Carrier Screening Market forecast
- Carrier Screening Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Technology
10 Market Segmentation by Test
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global carrier screening market: Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fulgent Genetics Inc., Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising trends of next-generation sequencing (NGS) technology in carrier screening."
According to the report, one of the major drivers for this market is the rising prevalence of genetic diseases and disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- CENTOGENE NV
- Danaher Corp.
- DiaSorin SpA
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Fulgent Genetics Inc.
- Gene By Gene Ltd
- Illumina Inc.
- Invitae Corp.
- Laboratory Corp. of America Holdings
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
- Otogenetics Corporation
- Quest Diagnostics Inc.
- Sema4 OpCo Inc.
- Thermo Fisher Scientific Inc.
